Deducing Insulin-Producing Cells from Goat Adipose Tissue-Derived Mesenchymal Stem Cells.

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Endocrinology

Background:

• Diabetes mellitus is characterized by high blood glucose due to insufficient insulin production.
• Mesenchymal stem cells (MSCs) show promise for regenerative therapies.
• Goat adipose-derived mesenchymal stem cells (AD-MSCs) were investigated for their therapeutic potential.

Purpose of the Study:

• To explore the potential of AD-MSCs to transdifferentiate into pancreatic islet-like cells.
• To establish a model for studying glucose homeostasis.
• To develop building blocks for diabetes drug discovery and regenerative therapies.

Main Methods:

• Isolation, in vitro culture, and characterization of goat AD-MSCs.
• In vitro transdifferentiation of AD-MSCs into insulin-producing islet-like cells using a specific cocktail of growth factors and compounds.
• Analysis of gene and protein expression of pancreatic markers in transdifferentiated cells.

Main Results:

• Characterized AD-MSCs expressed MSC-specific markers and differentiated into mesodermal lineages.
• Transdifferentiated cells expressed key pancreatic endoderm transcripts (PDX1, NGN3, PAX6, PAX4, ISL1, GLUT2) and proteins (PDX1, INS, ISL1).
• The islet-like cells exhibited significant glucose-dependent insulin release.

Conclusions:

• Goat AD-MSCs can be successfully transdifferentiated into functional islet-like cells.
• This study provides a foundation for regenerative therapies for diabetes.
• The findings contribute to understanding glucose homeostasis and advancing diabetes research.